Structural basis for allosteric regulation of Human Topoisomerase IIα

Arnaud Vanden Broeck1,2, Christophe Lotz1,2, Robert Drillien1,2

  • 1Université de Strasbourg, CNRS, INSERM, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.

Insights

Human topoisomerase IIα (Top2α) is crucial for DNA topology and a cancer therapy target. Cryo-EM structures reveal its full assembly, detailing allosteric mechanisms and the C-terminal domain

Area of Science:

  • Molecular biology
  • Structural biology
  • Biochemistry

Background:

  • Human topoisomerase IIα (Top2α) is essential for DNA topology regulation and chromosome organization.
  • Top2α is a key target for anticancer drugs, forming complexes with DNA.
  • Limited structural data exists for the full Top2α enzyme, hindering understanding of its allosteric regulation and C-terminal domain (CTD) function.

Purpose of the Study:

  • To determine the cryo-electron microscopy (cryo-EM) structures of the entire human Topo IIα nucleoprotein complex.
  • To elucidate the molecular mechanisms underlying allosteric regulation between Top2α domains.
  • To investigate the role of the C-terminal domain (CTD) in Top2α activity.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) was used to solve structures of the human Topo IIα nucleoprotein complex.
  • Structures were obtained at subnanometer resolutions (3.6–7.4 Å).
  • Analysis focused on different conformational states of the enzyme.

Main Results:

  • Novel cryo-EM structures of the complete human Topo IIα nucleoprotein complex in various conformations were obtained.
  • The structures reveal molecular details of allosteric communication between the ATPase and DNA binding/cleavage domains.
  • A linker connecting the DNA-binding/cleavage domain to the CTD was identified, highlighting its role in modulating enzyme activity.

Conclusions:

  • The study provides unprecedented structural insights into the full human Topo IIα enzyme.
  • Understanding Top2α allosteric mechanisms and CTD function opens new avenues for cancer therapy development.
  • The findings facilitate further research into Top2α regulation, including post-translational modifications.

Related Concept Videos

Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
61.7K
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
33.3K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.1K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.2K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.3K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.5K